Human serum albumin has been conjugated to 1-(p-benzenediazonium)(ethylenedinitrilo)tetraacetic acid, a powerful chelating agent, and radioactive "'1indium ions have been added specifically to the chelating groups. The product, with a specific radioactivity of about 1 mCi/mg of protein, was employed as a radiotracer in scintillation scanning studies with human volunteers. Results show that 48 hr after injection, practically all of the label remains attached to albumin. This is confirmed by electrophoresis of serum proteins; 7 days after injection, 85% of the radioactivity in the serum is still in the albumin fraction. These observations agree with in vitro studies of the labeled albumin in human serum, where loss of the metal ion from the chelating group to the protein transferrin amounts to less than 3% after 1 week and less than 5% after 2 weeks. A metal ion may be attached to a biological molecule by means of a "bifunctional" chelating agent capable of forming a covalent bond to the desired molecule. The conjugation of a derivative of EDTA to a large molecule permits the addition of any of a number of metal ions to form a stable chelate. In principle, this can lead to the utilization of the physical properties of various metal ions in a broad range of applications. Of particular importance is the tagging of certain biological molecules with short-lived radionuclides, and the use of these tagged molecules in medical diagnosis (1).
Measurements of the distribution of label in mice up to 23 days after injection suggest that metabolism of the labeled protein does not lead to binding of indium ions by transferrin. The binding of indium and other metal ions by transferrin has previously posed a major impediment to the use of metal chelates for in vivo diagnostic procedures. Demonstration of the kinetic inertness of the chelate in these experiments suggests the use of related chelates as physical probes of biological systems.
A metal ion may be attached to a biological molecule by means of a "bifunctional" chelating agent capable of forming a covalent bond to the desired molecule. The conjugation of a derivative of EDTA to a large molecule permits the addition of any of a number of metal ions to form a stable chelate. In principle, this can lead to the utilization of the physical properties of various metal ions in a broad range of applications. Of particular importance is the tagging of certain biological molecules with short-lived radionuclides, and the use of these tagged molecules in medical diagnosis (1) .
A case in point is the use of chelates containing radioisotopes of indium for tracer studies. The intravenous injection of such compounds into human patients often leads to the binding of a large fraction of the radioactive metal by the serum protein transferrin, with the result that the observed behavior of the radionuclide is characteristic of the transferrin-indium complex (2, 3) . The rapid action of apo-transferrin in removing trivalent iron from chelates is also well known (4, 5) . Before biomolecules labeled with indium chelates can be considered valid radioindicators in vivo, it must be shown that the chelates are thermodynamically stable or kinetically inert to the extent that loss of indium is negligible.
Previously, we have studied the metabolism of proteins conjugated with indium chelates by measuring the biological lifetime of the label in mice and by observing the distribution of radioactivity among, serum proteins in rabbits (1, 6) . The results of these studies suggested that the protein-chelate conjugates were reasonably stable in vivo, but that as much as 50% of the metal ion might eventually become bound to transferrin and be sequestered in the liver and bone marrow. The present studies were undertaken to provide a detailed account of the behavior of carrier-free amounts of the albumin-chelate conjugate, both in vivo and under physiological conditions in vitro.
MATERIALS AND METHODS
All reagents were the purest commercially available products, used without further purification except where noted. Chromatographic columns and materials were obtained from BioRad Laboratories, Richmond, Calif. 94804.
Azoprotein. The "bifunctional" chelating agent 1-(p-benzenediazonium)-(ethylenedinitrilo)tetraacetic acid was prepared as described previously (6) . Azoalbumin was prepared by direct addition, at 40, of a 10-fold molar excess of a 4.4 mM solution of this chelating agent in 0.8 M HC1 to an unbuffered solution of human serum albumin (0.1 mM), with the pH kept between 7 and 10 by addition of 1 M NaOH. For the experiments described here, the average albumin molecule contained 1.3 chelating groups, of which approximately 20% were attached to histidine residues and the remainder to lysine residues (practically no azotyrosine was detected). Approximately 40% of the protein-bound EDTA groups were available for the binding of indium ions. These experiments will be described in detail elsewhere (Leung and Meares, submitted for publication).
Chelation of Indium. Because of the affinity between serum albumin and various metal ions (7) , the addition of indium ions only to the EDTA groups on azoalbumin requires that the intrinsic metal-binding sites of the protein be masked in some way. It was previously reported (6) than 98% of the indium is bound to the azoalbumin 10 min after mixing. Azoalbumin labeled according to this procedure was used for the studies with human patients. For the in vitro experiments, the radioactive azoprotein was passed through a 0.7 X 16 cm column containing Bio-Gel P-300 to remove the small amount of albumin dimer present. Fig. 1 . Daily blood samples were obtained for 2 weeks, and cellulose acetate electrophoresis was carried out on the plasma using barbital buffer at pH 8.6 , and applying 18 V/cm for 1 hr. The cellulose acetate strips were cut into 1-cm sections, and each section was assayed for radioactivity in a well scintillation counter. In this system transferrin runs 2 cm from the origin, and albumin between 5 and 6 cm which allows easy separation of these two proteins. Plasma samples were also counted daily in the well counter. Radioactivity remaining in the plasma is shown in Fig. 2 ; the straight line was determined by a least-squares fit to the last six points, which yielded a half-life of 7.0 + 0.1 days for the final phase.
Human Serum In Vitro. Blood was taken from a healthy adult male donor. It was allowed to clot for 45 min at room temperature and then centrifuged. The serum was drawn off with a pipet and recentrifuged. A mixture of 6 ml of serum and 250 ,l of radioactive azoprotein (0.02 mg of azoprotein per ml of serum) was passed through a sterile 0.22 Am filter and apportioned into three sterile vials. A mixture of 6 ml of serum and 100 ,l of NO2Ph-EDTA("llIn) was prepared similarly. The vials were placed in an incubator kept at 37 ± 0.50. An air/CO2 mixture (95%/5%) was passed through the incubator so that the pH of the serum samples remained at 7.6 + 0.1 during the experiment.
At intervals, aliquots were taken and analyzed by polyacrylamide gel electrophoresis. The system employed was similar to that of Davis (8) , except that the 6-cm running gel contained 6% acrylamide, and no large-pore gel was used. The electrophoresis was done in a Bio-Rad jacketed cell at 20 at 20 V/cm until the bromphenol blue tracking dye was 1 cm from the bottom. For each sample, gels were run in triplicate; one gel was stained with Coomassie brilliant blue, and the other two were frozen, cut into 2-mm slices, and assayed for radioactivity on a Beckman gamma-3l0 radiation counter.
At the end of 2 weeks, bovine-blood agar petri plates were inoculated with each serum mixture; no bacterial growth was observed after 72 hr at 37°. Addition of 1"'InCl3 to the 2-week-old incubation mixture demonstrated that the transferrin still retained its metal-binding avidity.
Distribution in Mice. To study the time course of the distribution of radioactive azoalbumin in vivo, we injected BALB/c mice with approximately 1 MiCi of radioactive azoprotein in 0.2 ml of saline. The rate of excretion was determined from whole-body radioactivity measurements in a group of three mice over 23 days, and compared with similar studies using "1'InCl3 and 131I-albumin. Also, groups of three mice were sacrificed on day 1, 3, 7, 10, and 23 after injection, and the radioactivity in the blood, lungs, liver, spleen, kidneys, muscle, and bone (including marrow) was measured. At 7 days, 85% of the radioactivity was still in the albumin fraction. All points have been decay-corrected.
RESULTS

Distribution in man
The plasma disappearance of 1.4 mCi of "'In-labeled human serum albumin was followed for 16 days in a human volunteer who was also studied by scintillation scanning. As shown in Fig.  1 , an excellent scan of the whole body showed the large vascular structures to be well outlined over a 48 hr period, with no evidence of the bone marrow accumulation which is seen when "I'In-transferrin is formed. The biological half-life in plasma was 7.0 ± 0.1 days (Fig. 2) , with 85% of the plasma radioactivity still in the albumin fraction on day 7. Human serum After polyacrylamide gel electrophoresis of the serum samples, the stained gels were similar in appearance to those of Davis (8) . The bands of the stained gels were studied for changes during the 2-week incubation. The only significant change observed 7-LU GaCZ-) came after 258 hr, when slow evaporation led to some aggregation of the proteins. Measurements of radioactivity versus migration distance obtained from electrophoretic analysis of the serum-NO2Ph-EDTA("'IIn) mixture permitted easy determination of the fraction of radioactivity associated with transferrin. As shown in Fig. 3 , this quantity is 5% of the total 11In after 333 hr of incubation. It was also observed that a small amount of the intact chelate NO2Ph-EDTA("'IIn) migrates with albumin during the electrophoresis.
Electrophoresis of the mixture of radioactive azoalbumin with serum revealed slow separation of some of the indium chelate from albumin, amounting to 6% of the total after 333 hr. Similar behavior has been reported for other azoproteins (9) .
The time course of this decomposition is shown in Fig. 3 ; note that the initial mixture contained 2.3% "free" chelate.
The loss of indium ions from azoalbumin to transferrin is difficult to quantitate with this electrophoretic system because the dimer of albumin migrates only slightly faster than trans-TIME <HR> FIG. 3. Time course of the decomposition of NO2Ph-EDTA(111In) and "'In-azoalbumin in serum. Ordinate gives the percent of the total II'n appearing in each product: "1'In-transferrin from NO2Ph-EDTA( I'In) (A); albumin dimer plus 1"'In-transferrin from II'In-azoalbumin (0); "free" chelate from "1In-azoalbumin (0).
Chemistry: Meares et al. ferrin. The sum of the radioactivity in the albumin-dimer band and the transferrin band is plotted in Fig. 3 . After 2 weeks of incubation, this quantity represents less than 5% of the total 111In, and a significant portion of this appears to be due to the formation of albumin dimers containing 'Illn-azoalbumin.
Distribution in mice
The retention of radioactive azoalbumin by BALB/c mice is shown in Fig. 4 , along with the results of similar measurements for "'InCl3 and '31I-albumin. For "'In-azoalbumin, the whole-body retention of radioactivity falls rapidly to about 40% after 3 days and finally reaches a plateau with about 10% of the label retained after 16 days. Radioactivity from '11In-azoalbumin is retained mainly in the liver, with a comparatively small quantity in the marrow; this will be discussed in detail elsewhere. Because of the improved labeling procedure, these results differ from those published previously (1). These experiments suggest that metabolism of the azoalbumin in mice leads mainly to the excretion of intact chelates rather than to the production of indium ions.
DISCUSSION
Upon injection of simple salts or weak chelates of indium into the human circulatory system, the metal rapidly becomes bound to transferrin and then is deposited slowly in the bone marrow (2, 3); trivalent iron is bound and transported in a similar way. The exchange of iron between chelates and transferrin has been studied in some detail, and it has been reported that, under physiological conditions, the loss of iron from many of the most stable chelates to transferrin proceeds rapidly (4, 5) . Since iron and indium form chelates of comparable stability with EDTA and related polyaminocarboxylate chelating agents (10) , it was expected that exchange of indium from the chelates used in this work to transferrin might also occur at a significant rate.
We have demonstrated by these experiments that, for the bifunctional chelating agents employed, exchange of indium to transferrin proceeds very slowly in vvo and in vitro. These results provide forceful evidence that the technique of labeling biological molecules with chelates containing radioactive indium has significant applications to nuclear medicine (11, 12) .
Chelating agents which can be attached to macromolecules, and which form metal chelates that are stable under physiological conditions, provide a new approach to the study of biological systems. It is expected that +N2Ph-EDTA and related compounds will form stable chelates with metal ions having a variety of spectroscopic and radioactive properties. Such chelates may find many applications as physical probes, or "reporter groups," for investigation of the structural and dynamic properties of biological systems.
